AU5637499A - Chemical compounds iii - Google Patents

Chemical compounds iii

Info

Publication number
AU5637499A
AU5637499A AU56374/99A AU5637499A AU5637499A AU 5637499 A AU5637499 A AU 5637499A AU 56374/99 A AU56374/99 A AU 56374/99A AU 5637499 A AU5637499 A AU 5637499A AU 5637499 A AU5637499 A AU 5637499A
Authority
AU
Australia
Prior art keywords
chemical compounds
compounds iii
iii
chemical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56374/99A
Inventor
David Reginald Adams
Claire Elizabeth Dawson
Jonathan Richard Anthony Roffey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ligand UK Research Ltd
Original Assignee
Cerebrus Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerebrus Pharmaceuticals Ltd filed Critical Cerebrus Pharmaceuticals Ltd
Publication of AU5637499A publication Critical patent/AU5637499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU56374/99A 1998-09-01 1999-09-01 Chemical compounds iii Abandoned AU5637499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9819020 1998-09-01
GBGB9819020.0A GB9819020D0 (en) 1998-09-01 1998-09-01 Chemical compounds III
PCT/GB1999/002883 WO2000012482A2 (en) 1998-09-01 1999-09-01 Indazole derivatives with 5-ht2 receptor activity

Publications (1)

Publication Number Publication Date
AU5637499A true AU5637499A (en) 2000-03-21

Family

ID=10838155

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56374/99A Abandoned AU5637499A (en) 1998-09-01 1999-09-01 Chemical compounds iii

Country Status (3)

Country Link
AU (1) AU5637499A (en)
GB (1) GB9819020D0 (en)
WO (1) WO2000012482A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
US7005443B1 (en) 2000-03-17 2006-02-28 Alcon, Inc. 5-Hydroxy indazole derivatives for treating glaucoma
CN1450995A (en) * 2000-03-17 2003-10-22 爱尔康公司 5-hydroxy indazole derivatives for treating glaucoma
CA2428905A1 (en) 2000-11-20 2002-05-23 Biovitrum Ab Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
SE0004245D0 (en) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
EP1343768A1 (en) 2000-12-20 2003-09-17 Bristol-Myers Squibb Pharma Company Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
WO2004000830A1 (en) 2002-06-19 2003-12-31 Biovitrum Ab Novel compounds, their use and preparation
CL2004000826A1 (en) 2003-04-25 2005-03-04 Pfizer USE OF AN AGONIST FOR THE 5-HT2C RECEPTOR TO PREPARE A USEFUL MEDICINAL PRODUCT IN THE TREATMENT OF URINARY INCONTINENCE CAUSED BY STRESS, WITH THE CONDITION THAT THE AGONIST IS NOT 1- [6-CHLORINE-5- (TRIFLUOROMETIL) -2- PIRIDINIL] PIPERAZINA (ORG-129
GB0314967D0 (en) 2003-06-26 2003-07-30 Hoffmann La Roche Piperazine derivatives
EP2248524A3 (en) 2004-08-25 2011-03-09 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
EP1799640A4 (en) * 2004-09-27 2009-09-02 Organix Inc Indole compounds useful as serotonin selective agents
EP1869000A1 (en) 2005-03-31 2007-12-26 Pfizer Products Incorporated Cyclopentapyridine and tetrahydroquinoline derivatives
EP2742936A1 (en) 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
US20100266504A1 (en) 2007-11-15 2010-10-21 Takahiro Matsumoto Condensed pyridine derivative and use thereof
KR101062376B1 (en) 2008-04-10 2011-09-06 한국화학연구원 Novel indole carboxylic acid bispyridyl carboxamide derivatives, preparation method thereof and composition containing the same as an active ingredient
EP2510949A4 (en) 2009-12-11 2013-11-13 Astellas Pharma Inc Therapeutic agent for fibromyalgia
WO2015066344A1 (en) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists and compositions and methods of use
EP3733204A4 (en) 2017-12-27 2021-09-15 Takeda Pharmaceutical Company Limited Therapeutic agent for stress urinary incontinence and fecal incontinence

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0494774A1 (en) * 1991-01-11 1992-07-15 MERCK SHARP & DOHME LTD. Indazole-substituted fivemembered heteroaromatic compounds
JPH08165276A (en) * 1994-12-14 1996-06-25 Dainippon Pharmaceut Co Ltd 2-akylamino-1-phenylethanol derivative
JP3560986B2 (en) * 1997-01-13 2004-09-02 山之内製薬株式会社 5-HT2C receptor agonist and aminoalkylindazole derivative

Also Published As

Publication number Publication date
WO2000012482A2 (en) 2000-03-09
WO2000012482A3 (en) 2000-05-25
GB9819020D0 (en) 1998-10-28

Similar Documents

Publication Publication Date Title
AU2093597A (en) Chemical compounds
GB9800428D0 (en) Chemical compounds
GB9811159D0 (en) Chemical compounds
GB9812709D0 (en) Chemical compounds
AU5052199A (en) Chemical compounds
GB9819382D0 (en) Chemical compounds I
AU1424200A (en) Compounds
GB9812088D0 (en) Chemical compounds
AU5637499A (en) Chemical compounds iii
AU4501699A (en) Aminoazole compounds
GB9804343D0 (en) Chemical compounds
GB9928414D0 (en) Chemical compounds III
AU6104599A (en) Chemical compounds viii
AU1434500A (en) Compounds
GB9804861D0 (en) Chemical compounds
AU1872900A (en) Chemical compounds
AU5050899A (en) Chemical compounds
GB9801812D0 (en) Chemical compounds
AU5661399A (en) Compounds
GB9802028D0 (en) Chemical compounds
AU5689400A (en) Chemical compounds
AU3715899A (en) Di-peroxy compounds
GB9809161D0 (en) Chemical compounds
GB9801499D0 (en) Chemical compounds iii
AUPP298598A0 (en) Neurologically-active compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase